Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis
暂无分享,去创建一个
[1] U. Ungerstedt,et al. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat , 1987, Neurochemistry International.
[2] P. McHugh,et al. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches , 1987, Brain Research.
[3] C. Jacquot,et al. Cholecystokinin and bombesin in vagotomized or intact lean and obese rats: Effects on neurotransmitters in brain , 1987, Neuropharmacology.
[4] J. Morley,et al. Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. , 1987, Science.
[5] Y. Hagino,et al. Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice , 1987, Neuropeptides.
[6] A. Crossman,et al. Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders , 1987, Neuroscience.
[7] T. Moroji,et al. A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain , 1986, Brain Research.
[8] J. Hutchison,et al. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists , 1986, Brain Research.
[9] G. Zetler. Neuropharmacological Profile of Cholecystokinin‐like Peptides , 1985, Annals of the New York Academy of Sciences.
[10] M. Palkovits,et al. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] K. Inouye,et al. Effects of caerulein-related peptides on cholecystokinin receptor bindings in brain and pancreas. , 1985, Biochemical pharmacology.
[12] H. Yokoo,et al. Effect of systemically administered caerulein on dopamine metabolism in rat brain , 1984, Brain Research.
[13] J. Belleroche,et al. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat , 1984, Neuroscience Letters.
[14] K. Kawasaki,et al. Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system. , 1983, Life sciences.
[15] M. Starr. Influence of peptides on 3H-dopamine release from superfused rat striatal slices , 1982, Neurochemistry International.
[16] J. Morley,et al. The effect of vagotomy on the satiety effects of neuropeptides and naloxone. , 1982, Life sciences.
[17] G. P. Smith,et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.
[18] R. Innis,et al. Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. , 1981, Life sciences.
[19] S. Paul,et al. Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors , 1981 .
[20] J. Christophe,et al. Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: A study by high pressure liquid chromatography , 1981, Regulatory Peptides.
[21] G. Zetler. Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol , 1981, Neuropharmacology.
[22] B. Penke,et al. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice. , 1981, European journal of pharmacology.
[23] T. Hökfelt,et al. Evidence for coexistence of dopamine and CCK in meso-limbic neurones , 1980, Nature.
[24] J. D. De Mey,et al. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Rehfeld,et al. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. , 1978, The Journal of biological chemistry.
[26] R. Yalow,et al. Cholecystokinin and its COOH-terminal octapeptide in the pig brain. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. Dockray,et al. Immunochemical evidence of cholecystokinin-like peptides in brain , 1976, Nature.
[28] S. Lal,et al. Cholecystokinin and schizophrenia. , 1986, Progress in brain research.
[29] L. Pellegrino,et al. stereotaxic atlas of the rat brain , 1967 .